Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis

Simple item page
dc.contributor.authorCui, Ruien_US
dc.contributor.authorYu, Jieen_US
dc.contributor.authorKuang, Mingen_US
dc.contributor.authorDuan, Fengen_US
dc.contributor.authorLiang, Pingen_US
dc.date.accessioned2020-11-18T10:08:19Z
dc.date.available2020-11-18T10:08:19Z
dc.date.issued2020-05
dc.description.abstractWe aim to evaluate the efficacy and safety of microwave ablation (MWA) versus other treatment modalities for hepatocellular carcinoma (HCC). This study was registered in Prospero (registration number CRD42017057046). A complete electronic search was conducted for studies on MWA versus other interventions for HCC using PubMed, EMBASE, Cochrane Library databases, and ISI Web of Science. Randomized and non-randomized clinical trials were included. Data on technical efficacy, local tumor progression (LTP), overall survival (OS), progression-free survival (PFS), and major complications were extracted from included studies and combined to be analyzed via random effects models. OS was set as the primary outcome measure. Fifteen clinical studies were identified. When comparing MWA with radiofrequency ablation (RFA), no significant difference was found in 3-year OS rates (odds ratio [OR] 0.94, 95% confidence interval [CI] 0.66–1.34, P = 0.74), 5-year OS rates (OR 0.83, 95% CI 0.58–1.18, P = 0.29), 3-year PFS rates (OR 1.05, 95% CI 0.77–1.43, P = 0.74), 1-year LTP rate (OR 1.28, 95% CI 0.52–3.18,P = 0.59), technical efficacy rate (OR 1. 35, 95% CI 0. 85–2.15, P = 0.20), and major complication rate (OR 1.04, 95% CI 0.56–1.93, P = 0.90). When comparing MWA with hepatic resection, the 3-year OS rate was not significantly different (OR 0.89, 95% CI 0.59–1.35, P = 0.59). Compared with RFA and hepatic resection, MWA showed similar safety and efficacy for HCC, especially in OS rate and PFS. However, high-quality clinical trials are needed to validate the superiority of MWAen_US
dc.identifier.affiliationsDepartment of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853; Department of Ultrasonography, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510000, Chinaen_US
dc.identifier.affiliationsDepartment of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, Chinaen_US
dc.identifier.affiliationsDivision of Interventional Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou 510080, Chinaen_US
dc.identifier.affiliationsDepartment of Interventional Radiology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, Chinaen_US
dc.identifier.affiliationsDepartment of Interventional Ultrasound, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, Chinaen_US
dc.identifier.citationCui Rui, Yu Jie, Kuang Ming, Duan Feng, Liang Ping. Microwave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysis. Journal of Cancer Research and Therapeutics. 2020 May; 16(2): 379-386en_US
dc.identifier.issn0973-1482
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/213828
dc.languageenen_US
dc.publisherWolters Kluwer India Pvt. Ltd.en_US
dc.relation.issuenumber2en_US
dc.relation.volume16en_US
dc.source.urihttps://dx.doi.org//10.4103/jcrt.JCRT_403_19en_US
dc.subjectHepatocellular carcinomaen_US
dc.subjectmeta‑analysisen_US
dc.subjectmicrowaveen_US
dc.subjectoverall survivalen_US
dc.subjectprogression‑free survivalen_US
dc.titleMicrowave ablation versus other interventions for hepatocellular carcinoma: A systematic review and meta-analysisen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijcrt2020v16n2p379.pdf
Size:
2.28 MB
Format:
Adobe Portable Document Format
Download
Collections
Journal of Cancer Research and Therapeutics